apoQlar secures funding and valuable partnership
Hamburg-based medtech startup apoQlar has closed a financing round led by venture capital firm YZR Capital. The exact amount was not named. The capital will be used to scale the new version of its mixed reality platform, VSI HoloMedicine, to further improve surgical planning, medical education and patient outcomes.
Using mixed reality to drive higher medical standards
apoQlar has also partnered with National University Health System (NUHS), Singtel, Infocomm Media Development Authority (IMDA) and Microsoft in Singapore. This joint initiative will enable a wide range of surgeons to use the immersive capabilities of the VSI HoloMedicine platform via mixed reality headsets such as the HoloLens 2 and other devices suitable for this technology.
The vision of apoQlar is to use Virtual Surgery Intelligence (VSI) to create a whole new standard of medicine and redefine everyday clinical practice. Processes will become faster, operations safer, training of specialists more effective and patient care more qualitative. Soon, doctors and all hospital staff shall be wearing mixed reality glasses. VSI displays important patient information in the glasses, which is processed by artificial intelligence, in 3-D in real space. For maximum surgical safety, these images are projected over the patient to make intraoperative adjustments.
